Toxicology for the Twenty-first Century

Overview

Journal Nature

Specialty Science

Date 2009 Jul 10

PMID 19587762

Citations 164

Authors

Thomas Hartung

Affiliations

Soon will be listed here.

Citing Articles

Editorial: Five grand challenges in toxicology.

Fadeel B, Alexander J, Antunes S, Dalhoff K, Fritsche E, Hogberg H Front Toxicol. 2025; 6:1533238.

PMID: 39906194 PMC: 11790662. DOI: 10.3389/ftox.2024.1533238.

Integration of nanobiosensors into organ-on-chip systems for monitoring viral infections.

Zhang J, Kim M, Lee S, Park S Nano Converg. 2024; 11(1):47.

PMID: 39589620 PMC: 11599699. DOI: 10.1186/s40580-024-00455-0.

Advancing Toxicity Predictions: A Review on to Extrapolation in Next-Generation Risk Assessment.

Han P, Li X, Yang J, Zhang Y, Chen J Environ Health (Wash). 2024; 2(7):499-513.

PMID: 39473885 PMC: 11504544. DOI: 10.1021/envhealth.4c00043.

Reproductive toxicology: keeping up with our changing world.

Miller L, Feuz M, Meyer R, Meyer-Ficca M Front Toxicol. 2024; 6:1456687.

PMID: 39463893 PMC: 11502475. DOI: 10.3389/ftox.2024.1456687.

ToxDAR: A Workflow Software for Analyzing Toxicologically Relevant Proteomic and Transcriptomic Data, from Data Preparation to Toxicological Mechanism Elucidation.

Jiang P, Zhang Z, Yu Q, Wang Z, Diao L, Li D Int J Mol Sci. 2024; 25(17).

PMID: 39273492 PMC: 11394870. DOI: 10.3390/ijms25179544.

References

Hareng L, Pellizzer C, Bremer S, Schwarz M, Hartung T . The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Reprod Toxicol. 2005; 20(3):441-52. DOI: 10.1016/j.reprotox.2005.04.003. View

Wood M, Pichard A, Gundert-Remy U, de Rooij C, Tissot S . The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applications. J Hazard Mater. 2005; 133(1-3):8-15. DOI: 10.1016/j.jhazmat.2005.07.089. View

Hoffmann S, Cole T, Hartung T . Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals. Regul Toxicol Pharmacol. 2005; 41(3):159-66. DOI: 10.1016/j.yrtph.2004.11.003. View

Kuiper H, Kleter G, Noteborn H, Kok E . Assessment of the food safety issues related to genetically modified foods. Plant J. 2001; 27(6):503-28. DOI: 10.1046/j.1365-313x.2001.01119.x. View

SCHARDEIN J, Schwetz B, Kenel M . Species sensitivities and prediction of teratogenic potential. Environ Health Perspect. 1985; 61:55-67. PMC: 1568765. DOI: 10.1289/ehp.856155. View

Hansson S, Ruden C . Evaluating the risk decision process. Toxicology. 2005; 218(2-3):100-11. DOI: 10.1016/j.tox.2005.10.003. View

Bottini A, Hartung T . Food for thought... on the economics of animal testing. ALTEX. 2009; 26(1):3-16. DOI: 10.14573/altex.2009.1.3. View

Leist M, Hartung T, Nicotera P . The dawning of a new age of toxicology. ALTEX. 2008; 25(2):103-14. View

Hoffmann S, Hartung T . Toward an evidence-based toxicology. Hum Exp Toxicol. 2006; 25(9):497-513. DOI: 10.1191/0960327106het648oa. View

10.

Olson H, Betton G, Robinson D, Thomas K, MONRO A, Kolaja G . Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000; 32(1):56-67. DOI: 10.1006/rtph.2000.1399. View

11.

Lotti M, Nicotera P . Toxicology: a risky business. Nature. 2002; 416(6880):481. DOI: 10.1038/416481a. View

12.

Purchase I . Fraud, errors and gamesmanship in experimental toxicology. Toxicology. 2004; 202(1-2):1-20. DOI: 10.1016/j.tox.2004.06.029. View

13.

Austin P, Mamdani M, Juurlink D, Hux J . Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. J Clin Epidemiol. 2006; 59(9):964-9. DOI: 10.1016/j.jclinepi.2006.01.012. View

14.

Hartung T, Leist M . Food for thought ... on the evolution of toxicology and the phasing out of animal testing. ALTEX. 2008; 25(2):91-102. DOI: 10.14573/altex.2008.2.91. View

15.

Basketter D, York M, McFadden J, Robinson M . Determination of skin irritation potential in the human 4-h patch test. Contact Dermatitis. 2004; 51(1):1-4. DOI: 10.1111/j.0105-1873.2004.00385.x. View

16.

Kola I, Landis J . Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov. 2004; 3(8):711-5. DOI: 10.1038/nrd1470. View

17.

MacGregor J . The future of regulatory toxicology: impact of the biotechnology revolution. Toxicol Sci. 2003; 75(2):236-48. DOI: 10.1093/toxsci/kfg197. View

18.

Hartung T . Toward a new toxicology - evolution or revolution?. Altern Lab Anim. 2009; 36(6):635-9. DOI: 10.1177/026119290803600607. View

19.

Pognan F . Genomics, proteomics and metabonomics in toxicology: hopefully not 'fashionomics'. Pharmacogenomics. 2004; 5(7):879-93. DOI: 10.1517/14622416.5.7.879. View

20.

Rietjens I, Alink G . Future of toxicology--low-dose toxicology and risk--benefit analysis. Chem Res Toxicol. 2006; 19(8):977-81. DOI: 10.1021/tx0601051. View